ERAS-10

N/A

Report date: 2023/05/22 10:17:17
NME

Base Information

Drug NameERAS-10
Drug Alias NameERAS-10
ClassificationSmall molecules
Mechanisms of ActionGTPase Ras inhibitorsMitogen-activated protein kinase inhibitors
TargetsGTPase RasMitogen-activated protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesErasca Inc
China Registration ClassN/A

Develop Information

Active CompaniesErasca Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A